Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Return on Equity (2018 - 2025)

Catheter Precision (VTAK) has disclosed Return on Equity for 8 consecutive years, with 2.45% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 159.0% to 2.45% in Q3 2025 year-over-year; TTM through Sep 2025 was 2.45%, a 159.0% decrease, with the full-year FY2024 number at 0.82%, up 382.0% from a year prior.
  • Return on Equity was 2.45% for Q3 2025 at Catheter Precision, up from 2.69% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.34% in Q1 2024 to a low of 3.89% in Q1 2023.
  • A 5-year average of 1.8% and a median of 1.54% in 2021 define the central range for Return on Equity.
  • Peak YoY movement for Return on Equity: crashed -289bps in 2023, then skyrocketed 355bps in 2024.
  • Catheter Precision's Return on Equity stood at 0.61% in 2021, then crashed by -302bps to 2.47% in 2022, then plummeted by -33bps to 3.28% in 2023, then surged by 66bps to 1.1% in 2024, then tumbled by -123bps to 2.45% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Return on Equity are 2.45% (Q3 2025), 2.69% (Q2 2025), and 1.59% (Q1 2025).